Practice Areas
Bio Life Sciences
In the fast-paced universe of start-ups and private capital, federal government partnerships and funding may be overlooked as potential strategies to attract private investment and advance the commercialization of pharmaceutical and medical device products. Such partnerships and opportunities provide an alternative, non-dilutive funding mechanism for companies with new technologies that fulfill a national and international need.
Fabiani & Company’s Life Sciences practice helps our clients realize the value of working with the federal government to advance their business objectives. Our strategists navigate the complex web of government programs to facilitate funding and research partnerships. From pre-clinical discovery and basic research and development to post market evaluation, the federal government can serve as a significant source of non-dilutive funding, in-kind services, and ultimately a market. Our team specializes in positioning clients to benefit from the strategic opportunities we identify.